References
1. Chang C, Ke D, Chen J: Essential fatty acids and human brain. Acta Neurologica Taiwanica 2009;18:231-241.
2. Ahmad A, Greiner R, Moriguchi T, et al: Effects of dietary omega-3 fatty acid on the morphology of the hippocampus. Journal of Neurochemistry 2000;74:88.
3. Haag M: Essential fatty acids and the brain. Canadian Journal of Psychiatry 2003;48:195-203.
3a. Cutuli D: Functional and structural benefits induced by omega-3 polyunsaturated fatty acids during aging. Current Neuropharmacology 2016;June 13th.
4. Horrocks L, Farooqui A: Docosahexaenoic acid in the diet: Its importance in maintenance and restoration of neural membrane function. Prostaglandins, Leukotrienes and Essential Fatty Acids 2004;70:361-372.
5. Colin J, Gregory-Paurn L, Lanhers M, et al: Membrane raft domains and remodeling in aging brain. Biochimie 2016;130:178-187.
6. Bourre J: Dietary omega-3 fatty acids and psychiatry. Journal of Nutrition, Health, And Aging 2005;9:31-38.
7. Ahmad A, Greiner R, Moriguchi T, et al: Effects of dietary omega-3 fatty acid on the morphology of the hippocampus. Journal of Neurochemistry 2000;74:88.
8. Orr S, Bazinet R: The emerging role of docosahexaenoic acid in neuroinflammation. Current Opinions in Investigational Drugs 2008;9:735-743.
9. Haag M: Essential fatty acids and the brain. Canadian Journal of Psychiatry 2003;48:195-203.
10. Horrocks L, Farooqui A: Docosahexaenoic acid in the diet: Its importance in maintenance and restoration of neural membrane function. Prostaglandins, Leukotrienes and Essential Fatty Acids 2004;70:361-372.
11. Sanchez-Villegas A, Henriquez P, Figueiras A, et al: Long chain omega-3 fatty acids intake, fish consumption and mental disorders in the SUN cohort. study. European Journal of Nutrition 2007;46:337-346.
12. Whalley L, Fox H, Wahle K, et al: Cognitive aging, childhood intelligence, and the use of food supplements: Possible involvement of n-3 fatty acids. American Journal of Clinical Nutrition 2004;80:1650-1657.
13. Nitta H, Kinoyama M, Watanabe A, et al: Effects of nutritional supplementation with antioxidant vitamins and minerals and fish oil on antioxidant status and psychosocial stress in smokers. Clinical Experimental Medicine 2007;7:179-183.
14. Delarue J, Matzinger O, Binnert C, et al: Fish oil prevents the adrenal activation elicited by mental stress in healthy men. Diabetes Metabolism 2003;29:289-295.
15. Schaefer E, Bongard V, Beiser A, et al: Plasma phosphatidylcholine docosahexaenoic acid content and risk of dementia and Alzheimer disease. The Framingham Heart Study. Archives of Neurology 2006;63:1545-1550.
16. Pjamondon H, Roberge M: Dietary PUFA supplements reduce memory deficits but not CA1 ischemic injury in rats. Physiology & Behavior 2008; July 22nd.
17. Sinclair A, Begg D, Mathai M, et al: Omega 3 fatty acids and the brain. Asia Pacific Journal of Clinical Nutrition 2007;16 (suppl):391-397.
18. Freeman M, Hibbeln J, Wisner K, et al: Omega-3 fatty acids: Evidence basis for treatment and future research in psychiatry. Journal of Clinical Psychiatry 2006;67:1954-1967.
19. Motluk A: A fatty diet can clog your brain as well as your coronary arteries. New Science 2001;169:10.
20. Lim S, Kim E, Kim A, et al: Nutritional factors affecting mental health. Clinical Nutrition Research 2016;5:143-152.
21. Kulzow N, Witte A, Kerti L, et al: Impact of omega-3 fatty acid supplementation on memory functions in healthy older adults. Journal of Alzheimers Disease 2016;51:713-725.
22. Parker G, Gibson N, Brotchie H, et al: Omega-3 fatty acids and mood disorders. American Journal of Psychiatry 2006;163:969-978.
23. Chiu C, Huang S, Shen W, et al: Omega-3 fatty acids for depression in pregnancy. American Journal of Psychiatry 2003;160:385.
24. Mamalakis G, Tornaritis M, Kafatos A: Depression and adipose essential polyunsaturated fatty acids. Prostaglandins, Leukotrienes and Essential Fatty Acids 2002;67:311-318.
25. Timonen M, Horrobin D, Jokelainen J, et al: Fish consumption and depression. Journal of Affective Disorders 2004;82:447-452.
26. Sontrop J, Campbell M: Omega-3 polyunsaturated fatty acids and depression. Preventive Medicine 2006;42:4-13.
27. Mamalakis G, Kalagerpoulos N, Andrikopoulos N, et al: Depression and long chain n-3 fatty acids in adipose tissue in adults from Crete. European Journal of Clinical Nutrition 2006;60:882-888.
28. Tanskanen A, Hibbeln J, Tuomilehto J, et al: Fish consumption and depressive symptoms in the general population of Finland. Psychiatric Services 2001;52:529-531.
29. Whalley L, Fox H, Wahle K, et al: Cognitive aging, childhood intelligence, and the use of food supplements: Possible involvement of n-3 fatty acids. American Journal of Clinical Nutrition 2004;80:1650-1657.
30. Richardson A, Burton J, Sewell R, et al: Docosahexaenoic acid for reading, cognition and behavior in children aged 7-9 years. PLoS One 2012;7:e43909.
31. Kuratko C, Barrett E, Nelson E, et al: The relationship of docosahexaenoic acid (DHA) with learning and behavior in healthy children: A review. Nutrients 2013;5:2777-2810.
32. Pu H, Jiang X, Wei Z, et al: Repetitive and prolonged omega-3 fatty acid treatment after traumatic brain injury enhances long-term tissue restoration and cognitive recovery. Cell Transplantation 2016; November 24th.
33. Grimm M, Mett J, Stahlmann C, et al: Eicosapentaenoic acid and docosahexaenoic acid increase the degradation of amyloid-beta by affecting insulin-degrading enzyme. Biochemistry and Cell Biology 2016;94:534-542.
34. Ren H, Luo C, Feng Y, et al: Omega-3 polyunsaturated fatty acids promote amyloid-beta clearance from the brain through mediating the function of the glymphatic system. FASEB Journal 2017;31:282-293.
35. Lim G, Calon F, Morihara T, et al: A diet enriched with the omega-3 fatty acid docosahexaenoic acid reduces amyloid burden in an aged Alzheimer mouse model. Journal of Neuroscience 2005;25:3042-3040.
36. Morris M, Evans D, Bienias J, et al: Consumption of fish and n-3 fatty acids and risk of incident Alzheimer disease. Archives of Neurology 2003;60:940-946.
37. Tukiainen T, Tynkkynen T, Makinen V, et al: A multi-metabolite analysis of serum by (1)H NMR spectroscopy: Early systemic signs of Alzheimer’s disease. Biochemical & Biophysical Research Communications 2008;August 9th.
38. Belkouch M, Hachem M, Elgot A, et al: The pleiotropic effects of omega-3 docosahexaenoic acid on the hallmarks of Alzheimer’s disease. Journal of Nutritional Biochemistry 2016;38:1-11.
39. Cederholm T: Fish consumption and omega-3 fatty acid supplementation for prevention or treatment of cognitive decline, dementia, or Alzheimer’s disease in older adults. Current Opinion in Clinical Nutrition and Metabolic Care 2017;20:104-109.
40. International Society for the Study of Fatty Acids and Lipids: ISSFAL Newsletter 2007;Winter 14(3):1-13.
41. Austria J, Richard M, Chahine M, et al: Bioavailability of alpha-linolenic acid in subjects after ingestion of three different forms of flaxseed. Journal of the American College of Nutrition 2008;27:214-221.
42. Omega-3s are “essential” fats that cannot be made by the body: https://www.hsph.harvard.edu/nutritionsource/omega-3-fats/
43. Huang T, Zandi P, Tucker K, et al: Benefits of fatty fish on dementia risk are stronger for those with APOE epsilon4. Neurology 2005;65:1409-1414.
44. Cederholm T, Salem N, Palmblad J: Omega-3 fatty acids in the prevention of cognitive decline in humans. Advances in Nutrition 2013; 4:672-676.
45. Hibbeln J, Nieminen L, Blasbalg T, et al: Healthy intakes of n-3 and n-6 fatty acids. American Journal of Clinical Nutrition 2006;83(suppl 6):1483S-1493S.